Orangewood Partners Invests in Barrington James 

October 12, 2022 – Private investment firm Orangewood Partners has made an investment in Barrington James, a global executive recruitment firm serving the pharmaceutical, biotechnology, and medical device sector. In partnering with Orangewood, Barrington James says it intends to enhance its global recruiting solutions, expand its client-service capabilities and support its ongoing commitment to developing and utilizing cutting-edge technology and software. The goal, says the firm, is to deliver greater access for its clients of exceptional talent on a permanent or temporary basis. Barrington James’ founder and CEO, Dan Barrington, will continue to lead the business alongside the existing leadership team, who will maintain a significant investment in the company.

“All of the whole of the life science and biotech sectors are poised for significant long-term growth, and competition for top talent in virtually every position is continuing to intensify,” said Neil Goldfarb, managing partner of Orangewood. “Barrington James’ deep focus on life sciences uniquely positions it to provide outstanding and highly bespoke service to its clients and capitalize further on this attractive opportunity. To that end, we are thrilled to bring Orangewood’s deep expertise in partnering with founders and track record of building healthcare-focused businesses to support Dan and his talented team. We look forward to working together as Barrington James continues to innovate and deepen its role as one of the premier life sciences focused recruiting firms.”

“This is an exciting day for Barrington James, our employees, and clients. Orangewood is a world-class investment firm with proven capabilities in supporting management teams and driving long-term value from its portfolio companies,” said Mr. Barrington. “We believe this partnership will enable us to continue to assist our top-class clients with their growth by providing exceptional talent to their teams, big or small.”

Delivering Niche Recruitment Services

“Our partnership and growth will allow us to deliver niche recruitment for new biotech’s and volume recruitment for leading pharmaceutical companies with speed and a standard of services that is second to none, on a temporary or permanent basis,” Mr. Barrington added. “I am grateful for the passion and dedication of our talented team around the world who recognize the important role that we play to support our clients whose work has never been more vital.”

K&L Gates served as legal advisor to Orangewood. Fairmount Partners served as exclusive financial advisor to Barrington James and Keystone Law served as its legal advisor. Brightwood Capital Advisors acted as sole lead arranger and administrative agent for the transaction.

Hunt Scanlon Media Launches M&A Advisory Network for Recruiters

Professional services firms – and executive recruiting outfits in particular – have a long history of finding their way through tough times. Many search firms have used this time to dust off their own continuity and succession plans, or to reconsider that merger or acquisition which was something of a nuisance when times were flush. Others have taken a hard look at their capitalization strategies. This crisis, like no other, has driven many of the most well-known and respected brands in the recruiting business to reassess everything about their businesses, top to bottom.

Behind the scenes, this has been an active year for executive recruitment firms. To meet their advisory needs, Hunt Scanlon Media earlier this year launched a new set of solutions to assist search firms and talent solutions providers seeking mergers, acquisitions, or funding connections. Founders Scott A. Scanlon and Christopher W. Hunt sit down to discuss the new venture and the state of the industry.

Founded in 2002, Barrington James provides life sciences companies with recruitment solutions that combine industry expertise with innovative recruitment technology. The firm’s specialist areas range from AI, biometrics, and clinical development to finance, medical affairs, commercial, quality assurance and computational sciences, and identifies placement opportunities ranging from contract and interim positions through to board and C-suite-level placements. Headquartered outside of London, Barrington James operates 12 offices in core life sciences clusters globally including in New York, Tokyo, Singapore, Raleigh, NC, and Greenville, SC supporting placements across Europe, North and South America, and Asia.

Founded in 2015, Orangewood Partners is a New York-based private investment firm with a long-term approach. Orangewood focuses on growth-oriented private transactions in partnership with founder-led businesses, management teams and entrepreneurs.

Related: Jensen Partners Secures Strategic Investment from JB Capital

Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media

Share This Article


Notify of
Inline Feedbacks
View all comments